Company data
Praxis Precision Medicines, Inc. employees and revenue per employee
PRAX · Biotechnology · $9.17B market cap
Praxis Precision Medicines, Inc. had 116 employees at the end of fiscal Dec 2024, up 41.5% from a year earlier. Revenue for the year was $8.6M, up 249.5% from a year earlier, or $74K per employee. Revenue and headcount both grew, and revenue grew faster.
Employees
116
+41.5% YoY
Revenue
$8.6M
+249.5% YoY
Revenue / employee
$74K
Peer median $457K
Rank in industry
95 of 110
Biotechnology
Open roles
144
1241 per 1,000 staff
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2024 | 116 | $8.6M | $74K | +41.5% | +249.5% |
| Dec 2023 | 82 | $2.4M | $30K | — | — |
Open roles on its job board: 144 (1241 per 1,000 staff, against its latest annual headcount), as of 2026-11-20. Tracked since 2026-10-03. No 90 day change yet.
Praxis Precision Medicines, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| CBIO Crescent Biopharma, Inc. | 44 | $10.8M | $246K | — |
| JANX Janux Therapeutics, Inc. | 109 | $10.0M | $92K | Hiring into decline |
| RLAY Relay Therapeutics, Inc. | 192 | $15.4M | $80K | Leaner |
| PRAX Praxis Precision Medicines, Inc. | 116 | $8.6M | $74K | Efficient growth |
| PGEN Precigen, Inc. | 160 | $9.7M | $61K | Efficient growth |
| ZBIO Zenas BioPharma, Inc. | 167 | $10.0M | $60K | Efficient growth |
| IMNM Immunome, Inc. | 177 | $6.9M | $39K | Hiring into decline |
| CRNX Crinetics Pharmaceuticals, Inc. | 594 | $7.7M | $13K | Efficient growth |
| AKTS Aktis Oncology, Inc. | 200,000 | $6.5M | $32 | — |
Questions about Praxis Precision Medicines, Inc.
- How many employees does Praxis Precision Medicines, Inc. have?
- Praxis Precision Medicines, Inc. reported 116 employees for the fiscal year ending Dec 2024, in the annual report it filed on February 28, 2025. That is up 41.5% from a year earlier.
- What is Praxis Precision Medicines, Inc.'s revenue per employee?
- Praxis Precision Medicines, Inc. brought in $8.6M of revenue in fiscal Dec 2024, which is $74K per employee. That ranks 95 of 110 companies we track in Biotechnology, where the median is $457K.
- Is Praxis Precision Medicines, Inc. hiring?
- Praxis Precision Medicines, Inc.'s public job board listed 144 open roles on November 20, 2026, about 1241 per 1,000 staff.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Outpick research
This page is the filings. The research is a membership.
On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare PRAX with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Praxis Precision Medicines, Inc.'s annual reports (Form 10-K), latest filed February 28, 2025. This is data, not a recommendation to buy or sell PRAX.